About CBDChamp
CBDChamp publishes daily CBD and hemp industry reporting powered by AI editorial tools and curated data feeds from 16+ industry sources. Our AI-powered approach enables comprehensive coverage of regulation, business, science, and product developments across the hemp and cannabinoid industry.
Our editorial system analyzes wire services and industry sources daily, synthesizing key developments into original editorial articles that are clearly labeled as AI-generated content.
Editorial Policy
- No unsubstantiated health claims.
- All factual claims are source-backed.
- Regulatory updates are prioritized and date-sensitive.
- Affiliate relationships are disclosed.
- AI-generated editorial content is clearly labeled and reviewed before publication.
- Wire stories link directly to their original sources for full attribution.
AI Content Disclosure
CBDChamp uses AI tools (including Grok) to generate editorial articles. All AI-generated articles are:
- Clearly labeled with an “AI Editorial” badge.
- Based on verified source material from established wire services.
- Reviewed for factual accuracy before publication.
- Never used to make unverified health, medical, or legal claims about CBD products.
FDA & Health Disclaimer
The content on CBDChamp is for informational purposes only and does not constitute medical advice. CBD products have not been evaluated or approved by the U.S. Food and Drug Administration (FDA) for the diagnosis, treatment, cure, or prevention of any disease. Always consult a qualified healthcare professional before using CBD or hemp-derived products, especially if you are taking medications or have a medical condition.
Contact & Corrections
If you believe any content on CBDChamp contains an error or requires a correction, please contact us. We are committed to maintaining factual accuracy in all our reporting.